Jakob Dupont
CIK 1553335 · View on SEC EDGAR ↗
First SEC filing: June 11, 2026 · Latest: June 11, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2026 | PYXS | S 10b5-1 | 35,000 | $3.06 | $107,100 | 38,741 Direct | -47.46% | Disposed | 3.1% (price as of 2026-08-21) |
| Nov. 16, 2022 | ATRA | S 10b5-1 | 1,124 | $4.49 | $5,047 | 154,540 Direct | -0.72% | Disposed | -91.7% (price as of 2026-08-21) |
| Nov. 16, 2022 | ATRA | S 10b5-1 | 3,218 | $4.49 | $14,449 | 155,664 Direct | -2.03% | Disposed | -91.7% (price as of 2026-08-21) |
| Aug. 16, 2022 | ATRA | S 10b5-1 | 4,124 | $5.03 | $20,744 | 158,882 Direct | -2.53% | Disposed | -92.6% (price as of 2026-08-21) |
| May 17, 2022 | ATRA | S 10b5-1 | 3,873 | $5.32 | $20,604 | 163,006 Direct | -2.32% | Disposed | -93.0% (price as of 2026-08-21) |
| March 1, 2022 | ATRA | S 10b5-1 | 2,221 | $9.86 | $21,899 | 166,879 Direct | -1.31% | Disposed | -96.2% (price as of 2026-08-21) |
| May 18, 2021 | ATRA | S 10b5-1 | 5,184 | $14.55 | $75,427 | 94,945 Direct | -5.18% | Disposed | -97.5% (price as of 2026-08-21) |
| Dec. 30, 2019 | GOSS | S | 40,000 | $15.00 | $600,000 | 0 Direct | -100.00% | Disposed | -99.0% (price as of 2026-08-21) |
| Dec. 27, 2019 | GOSS | S | 1,994 | $15.81 | $31,525 | 0 Direct | -100.00% | Disposed | -99.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 20, 2026 | PYXS | Stock Option (Right to Buy) | Common Stock (46,000) | $3.12 | Aug. 20, 2036 | 46,000 | Acquired |
| June 30, 2026 | PYXS | Stock Option (Right to Buy) | Common Stock (35,000) | $1.60 | Sept. 22, 2033 | 35,000 | Disposed |
| June 10, 2026 | BOLT | Stock Option (Right to Buy) | Common Stock (5,000) | $4.43 | June 9, 2036 | 5,000 | Acquired |
| March 24, 2026 | PYXS | Stock Option (Right to Buy) | Common Stock (45,867) | $1.36 | March 24, 2036 | 45,867 | Acquired |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (1,100) | $6.40 | May 26, 2035 | 1,100 | Disposed |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (1,100) | $5.44 | May 26, 2035 | 1,100 | Acquired |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (1,000) | $7.02 | April 30, 2035 | 1,000 | Disposed |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (1,000) | $5.44 | April 30, 2035 | 1,000 | Acquired |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (849) | $13.60 | Sept. 2, 2034 | 849 | Disposed |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (849) | $5.44 | Sept. 2, 2034 | 849 | Acquired |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (2,500) | $13.60 | Sept. 2, 2034 | 2,500 | Disposed |
| Dec. 12, 2025 | BOLT | Director Stock Option (Right to Buy) | Common Stock (2,500) | $5.44 | Sept. 2, 2034 | 2,500 | Acquired |
| May 27, 2025 | BOLT | Stock Option (Right to Buy) | Common Stock | — | May 26, 2035 | 1,100 | Acquired |
| May 1, 2025 | BOLT | Stock Option (Right to Buy) | Common Stock (20,000) | $0.35 | April 30, 2035 | 20,000 | Acquired |
| March 31, 2025 | PYXS | Stock Option (Right to Buy) | Common Stock (36,979) | $0.98 | March 31, 2035 | 36,979 | Acquired |
| Sept. 3, 2024 | BOLT | Stock Option (Right to Buy) | Common Stock (50,000) | $0.68 | Sept. 2, 2034 | 50,000 | Acquired |
| Sept. 3, 2024 | BOLT | Stock Option (Right to Buy) | Common Stock (16,984) | $0.68 | Sept. 2, 2034 | 16,984 | Acquired |
| Sept. 22, 2023 | PYXS | Stock Option (Right to Buy) | Common Stock (392,461) | $1.60 | Sept. 22, 2033 | 392,461 | Acquired |
| Aug. 23, 2023 | PYXS | Stock Option (Right to buy) | Common Stock (17,250) | $15.37 | Sept. 29, 2032 | 17,250 | Acquired |
| Aug. 23, 2023 | PYXS | Stock Option (Right to buy) | Common Stock (3,534) | $26.61 | Feb. 12, 2031 | 3,534 | Acquired |
| Aug. 23, 2023 | PYXS | Stock Option (Right to buy) | Common Stock (5,879) | $26.61 | Sept. 1, 2030 | 5,879 | Acquired |
| March 1, 2023 | ATRA | Employee Stock Option (Right to Buy) | Common Stock (317,987) | $3.91 | Feb. 28, 2033 | 317,987 | Acquired |
| March 1, 2022 | ATRA | Employee Stock Option (Right to Buy) | Common Stock (147,573) | $10.21 | Feb. 28, 2032 | 147,573 | Acquired |
| March 1, 2021 | ATRA | Employee Stock Option (Right to Buy) | Common Stock (81,327) | $17.10 | Feb. 28, 2031 | 81,327 | Acquired |
| May 14, 2020 | ATRA | Employee Stock Option (Right to Buy) | Common Stock (277,500) | $9.58 | May 13, 2030 | 277,500 | Acquired |
| Feb. 14, 2020 | GOSS | Stock Option (right to buy) | Common Stock (71,500) | $14.55 | Feb. 14, 2030 | 71,500 | Acquired |
| Dec. 30, 2019 | GOSS | Non-qualified stock option (Right to Buy) | Common Stock (40,000) | $10.71 | Dec. 13, 2028 | 40,000 | Disposed |
| Dec. 27, 2019 | GOSS | Non-qualified stock option (Right to Buy) | Common Stock (1,994) | $10.71 | Dec. 13, 2028 | 1,994 | Disposed |
| March 25, 2019 | GOSS | Stock Option (right to buy) | Common Stock (65,000) | $22.10 | March 25, 2029 | 65,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 7, 2019 | GOSS | Stock Option (Right to Buy)→ Common Stock (481,311) | 481,311 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ATRA
M.D.(6) EVP, Global Head of Research and Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | — | — | — | — | — | — | — | — |
| 2020 | $319,231 | $143,346 | — | $1,757,296 | — | — | $133,297 | $2,796,245 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $162,649 | — | — | — | — | — | $57,747 | $1,642,287 |
| 2018 | $20,167 | $85,000 | — | $3,422,122 | — | — | $3,165 | $3,530,454 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.